- Home
- LSPD vs APGE Comparison
LSPD vs APGE Comparison
Compare LSPD & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- APGE
- Stock Information
- Founded
- LSPD 2005
- APGE 2022
- Country
- LSPD Canada
- APGE United States
- Employees
- LSPD N/A
- APGE N/A
- Industry
- LSPD
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSPD
- APGE Health Care
- Exchange
- LSPD Nasdaq
- APGE Nasdaq
- Market Cap
- LSPD 1.7B
- APGE 1.8B
- IPO Year
- LSPD 2020
- APGE 2023
- Fundamental
- Price
- LSPD $8.93
- APGE $35.61
- Analyst Decision
- LSPD Buy
- APGE Strong Buy
- Analyst Count
- LSPD 13
- APGE 4
- Target Price
- LSPD $14.50
- APGE $91.33
- AVG Volume (30 Days)
- LSPD 1.2M
- APGE 745.2K
- Earning Date
- LSPD 05-15-2025
- APGE 03-03-2025
- Dividend Yield
- LSPD N/A
- APGE N/A
- EPS Growth
- LSPD N/A
- APGE N/A
- EPS
- LSPD N/A
- APGE N/A
- Revenue
- LSPD $1,053,623,000.00
- APGE N/A
- Revenue This Year
- LSPD $22.52
- APGE N/A
- Revenue Next Year
- LSPD $14.81
- APGE $795.25
- P/E Ratio
- LSPD N/A
- APGE N/A
- Revenue Growth
- LSPD 22.05
- APGE N/A
- 52 Week Low
- LSPD $8.54
- APGE $29.10
- 52 Week High
- LSPD $18.96
- APGE $66.80
- Technical
- Relative Strength Index (RSI)
- LSPD 23.04
- APGE 41.65
- Support Level
- LSPD $9.88
- APGE $38.18
- Resistance Level
- LSPD $10.38
- APGE $41.07
- Average True Range (ATR)
- LSPD 0.39
- APGE 2.13
- MACD
- LSPD -0.07
- APGE -0.26
- Stochastic Oscillator
- LSPD 16.63
- APGE 5.87
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.